Relative Bioavailability of Two Different Batches of a Linagliptin / Metformin Combination Tablet in Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the current study is to investigate the relative bioavailability of two
different batches of a 2.5 mg linagliptin / 1000 mg metformin fixed dose combination tablet
(FDC).